A phase IV, multicentre, open‐label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures. Issue 4 (5th May 2022) - Escobar, Miguel; Dunn, Amy; Quon, Doris; Trzaskoma, Ben; Lee, Lucy; Ko, Richard H.; Carpenter, Shannon L.